At Nanotein we recognize that the success of our business depends on the excellence of our people, and are dedicated to recruiting exceptional talent for our team.

About Us

We’re a small, core team of scientists and product developers, who are passionate about developing cutting-edge tools, that make a real and tangible difference in the lives of sick patients.

Beyond this though we’re also parents, former students, businesspeople, and we come from a variety of cultural backgrounds and life experiences. We support and value each other. Our management cultivates a company environment where professional development and a healthy work-life balance are nurtured.

What We Offer

Nanotein is poised to make a significant impact in the biotechnology sector. By joining our team, you will have the unique opportunity to help shape the future of cell therapy. We offer a competitive salary and benefits package, along with the chance to work at an innovative and supportive company.

Nanotein is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.

To apply, please submit your resume and cover letter detailing your relevant experience and interest in this role.

We look forward to transforming the future of cell therapy together!

Our Team

We’re a small and dedicated team of biochemists, cell biologists and bioengineers. We’re passionate about the impact that our technology can have on the cell therapy landscape and love collaborating with teams that are developing therapeutics. Learn more about our leadership, technical and commercial team members below!

Curtis Hodge, PhD

Co-Founder & CEO

Greg Hura, PhD

Co-Founder & CSO

Curtis D. Hodge, PhD

Co-Founder, CEO​

A structural biologist, protein biochemist, and immunologist by training, Curtis invented Nanotein’s core platform technology and acts as Nanotein’s CEO, driving the company’s day-to-day operations.

Prior to Nanotein, Curtis was a postdoc in Greg’s lab at LBNL. It’s here where the earliest iterations of Nanotein’s technology were born; work that ultimately culminated in the formation of Nanotein as a company and subsequent selection as a Top Emerging Biotech by UC Berkeley and UCSF’s QB3.

A proud native of Alberta, Canada Curtis earned his PhD in Biochemistry from the University of Alberta. From here he moved to California for a postdoc in cancer immunology at UC Berkeley, then to LBNL and the rest is history.

Greg L. Hura, PhD

Co-Founder, CSO​

Greg Hura is a Principal Investigator & Beamline Research Scientist at Lawrence Berkeley National Lab and an Associate Adjunct Professor at the University of California, Santa Cruz.

Greg has a PhD in Biophysics from UC Berkeley and was a pioneering developer of high-throughput small-angle X-ray Scattering (SAXS) internationally. He also created SAXS tools of wide spread use including the Vr similarity metric and HEAT map analyses for comprehensive characterizations of macromolecular conformational states in solution.

The technology and tools Greg developed and implemented at Berkeley lab were instrumental in the early development of Nanotein’s core technology.